ReviewHuman vaccines & immunotherapeutics2025
Animal models for enterovirus 71: Mechanisms, immunity, and applications.
Review in Human vaccines & immunotherapeutics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Neurotropism and interferon-dominated immune responses in a mouse-adapted coxsackievirus A16 infection model.Journal of virology · 2026Article
- Isolation and Identification of G8P[1] Bovine Rotavirus A Among Neonatal Diarrheic Calves in Yunnan, China.Animals : an open access journal from MDPI · 2026Article
- Establishment of disseminated neonatal echovirus 11 infection model in hFcRn transgenic mice.Virology journal · 2025Article
- Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Enterovirus 71 (EV-A71) is a leading cause of hand, foot, and mouth disease (HFMD) in young children and is associated with a risk of severe neurological complications. Although inactivated vaccines ae available, their limited cross-protective efficacy and the lack of approved antiviral treatments highlight the need for robust animal models to investigate viral pathogenesis and evaluate therapeutic interventions. This review provides a comprehensive overview of current EV-A71 animal models, particularly focusing on murine systems, and their applications in understanding disease mechanisms, supporting vaccine development, and developing antiviral strategies. The use of various EV-A71 strains, including clinical isolates, mouse-adapted strains, and infectious clones, in conjunction with rodent models such as BALB/c, ICR, and C57BL/6 neonatal mice, is examined. Additionally, transgenic, immunodeficient, and hybrid mouse models are also discussed for their ability to simulate key clinical features of infection, such as neurotropism, paralysis, and mortality. These models are indispensable for advancing therapeutic and vaccine research in pediatric infectious diseases.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.